Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2015

01.09.2015 | Original Article

High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma

verfasst von: Guohong Zhao, Jianqin Kang, Kai Jiao, Guanghui Xu, Lei Yang, Shanhong Tang, Hui Zhang, Ying Wang, Yongzhan Nie, Kaichun Wu, Daiming Fan, Hongbo Zhang, Dexin Zhang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Esophageal squamous cell carcinoma (ESCC) has a poor prognosis due to its high frequency of metastasis and invasion. Recent studies have suggested glucose-regulated protein 78KD (GRP78) may play important roles in progression and development of malignant tumors. However, the mechanisms of invasion and metastasis of ESCC in relation to GRP78 still remain obscure.

Aim

The aim of this study was to investigate the effect of GRP78 on invasion and metastasis of ESCC and to explore its potential mechanism.

Methods

GRP78 expression levels in ESCC tissues were examined by immunohistochemistry. RT-PCR and western blot were used to test the relative expression of GRP78 in non-metastatic and high-metastatic ESCC cells. In vitro and in vivo studies were both performed to investigate the role of GRP78 in invasion and metastasis of ESCC cells. The expression of metastasis-related proteins was examined by western blot in GRP78-depleted cells.

Results

The expression of GRP78 is correlated with invasion, metastasis and poor prognosis in ESCC patients. GRP78 expression was significantly higher in highly metastatic cells compared with ESCC non-metastatic cells. In addition, down-regulation of GRP78 significantly inhibited the metastatic potential of ESCC cells in both in vitro and in vivo studies. The expression of MMP-2 and MMP-9 were down-regulated in GRP78-depleted ESCC cells.

Conclusions

The present study demonstrated that GRP78 plays important roles in invasion and metastasis of ESCC, indicating that GRP78 might be used as a potential prognostic and therapeutic marker in patients with ESCC by modulating the expression of MMP-2 and MMP-9.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Zurück zum Zitat Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the US: the importance of tumor length and lymph node status. Cancer. 2002;95:1434–1443.CrossRefPubMed Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the US: the importance of tumor length and lymph node status. Cancer. 2002;95:1434–1443.CrossRefPubMed
3.
Zurück zum Zitat Lin DC, Du XL, Wang MR. Protein alterations in ESCC and clinical implications: a review. Dis Esophagus. 2009;22:9–20.CrossRefPubMed Lin DC, Du XL, Wang MR. Protein alterations in ESCC and clinical implications: a review. Dis Esophagus. 2009;22:9–20.CrossRefPubMed
4.
Zurück zum Zitat Kwong KF. Molecular biology of esophageal cancer in the genomics era. Surg Clin N Am. 2005;85:539–553.CrossRefPubMed Kwong KF. Molecular biology of esophageal cancer in the genomics era. Surg Clin N Am. 2005;85:539–553.CrossRefPubMed
5.
Zurück zum Zitat Ye Q, Yan Z, Liao X, et al. Muc1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13. Lab Invest. 2011;91:778–787.CrossRefPubMed Ye Q, Yan Z, Liao X, et al. Muc1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13. Lab Invest. 2011;91:778–787.CrossRefPubMed
6.
Zurück zum Zitat Koyama H, Iwata H, Kuwabara Y, Iwase H, Kobayashi S, Fujii Y. Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma. A study using in situ zymography. Eur J Cancer. 2000;36:2164–2170.CrossRefPubMed Koyama H, Iwata H, Kuwabara Y, Iwase H, Kobayashi S, Fujii Y. Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma. A study using in situ zymography. Eur J Cancer. 2000;36:2164–2170.CrossRefPubMed
7.
Zurück zum Zitat Uchikado Y, Natsugoe S, Okumura H, et al. Slug expression in the e-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 2005;11:1174–1180.PubMed Uchikado Y, Natsugoe S, Okumura H, et al. Slug expression in the e-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res. 2005;11:1174–1180.PubMed
8.
Zurück zum Zitat Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, Zucker S. Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. J Biol Chem. 2008;283:6232–6240.CrossRefPubMed Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, Zucker S. Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. J Biol Chem. 2008;283:6232–6240.CrossRefPubMed
10.
Zurück zum Zitat Xing X, Lai M, Wang Y, Xu E, Huang Q. Overexpression of glucose-regulated protein 78 in colon cancer. Clin Chim Acta. 2006;364:308–315.CrossRefPubMed Xing X, Lai M, Wang Y, Xu E, Huang Q. Overexpression of glucose-regulated protein 78 in colon cancer. Clin Chim Acta. 2006;364:308–315.CrossRefPubMed
11.
Zurück zum Zitat Uramoto H, Sugio K, Oyama T, et al. Expression of endoplasmic reticulum molecular chaperone GRP78 in human lung cancer and its clinical significance. Lung Cancer. 2005;49:55–62.CrossRefPubMed Uramoto H, Sugio K, Oyama T, et al. Expression of endoplasmic reticulum molecular chaperone GRP78 in human lung cancer and its clinical significance. Lung Cancer. 2005;49:55–62.CrossRefPubMed
12.
Zurück zum Zitat Zhang J, Jiang Y, Jia Z, et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis. 2006;23:401–410.CrossRefPubMed Zhang J, Jiang Y, Jia Z, et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis. 2006;23:401–410.CrossRefPubMed
13.
Zurück zum Zitat Daneshmand S, Quek ML, Lin E, et al. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol. 2007;38:1547–1552.CrossRefPubMed Daneshmand S, Quek ML, Lin E, et al. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol. 2007;38:1547–1552.CrossRefPubMed
14.
Zurück zum Zitat Du XL, Hu H, Lin DC, et al. Proteomic profiling of proteins dysregulted in chinese esophageal squamous cell carcinoma. J Mol Med (Berl). 2007;85:863–875.CrossRef Du XL, Hu H, Lin DC, et al. Proteomic profiling of proteins dysregulted in chinese esophageal squamous cell carcinoma. J Mol Med (Berl). 2007;85:863–875.CrossRef
15.
Zurück zum Zitat Dong D, Stapleton C, Luo B, et al. A critical role for GRP78/bip in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res. 2011;71:2848–2857.PubMedCentralCrossRefPubMed Dong D, Stapleton C, Luo B, et al. A critical role for GRP78/bip in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res. 2011;71:2848–2857.PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Li H, Song H, Luo J, Liang J, Zhao S, Su R. Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2012;31:39.PubMedCentralCrossRefPubMed Li H, Song H, Luo J, Liang J, Zhao S, Su R. Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2012;31:39.PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Kraljevic PS, Sedic M, Bosnjak H, Spaventi S, Pavelic K. Metastasis: new perspectives on an old problem. Mol Cancer. 2011;10:22.CrossRef Kraljevic PS, Sedic M, Bosnjak H, Spaventi S, Pavelic K. Metastasis: new perspectives on an old problem. Mol Cancer. 2011;10:22.CrossRef
18.
Zurück zum Zitat Li Z, Li Z. Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. Biochim Biophys Acta. 2012;1826:13–22.PubMed Li Z, Li Z. Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. Biochim Biophys Acta. 2012;1826:13–22.PubMed
19.
Zurück zum Zitat Dong D, Ni M, Li J, et al. Critical role of the stress chaperone GRP78/bip in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res. 2008;68:498–505.CrossRefPubMed Dong D, Ni M, Li J, et al. Critical role of the stress chaperone GRP78/bip in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res. 2008;68:498–505.CrossRefPubMed
20.
Zurück zum Zitat Baumeister P, Dong D, Fu Y, Lee AS. Transcriptional induction of GRP78/bip by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis. Mol Cancer Ther. 2009;8:1086–1094.PubMedCentralCrossRefPubMed Baumeister P, Dong D, Fu Y, Lee AS. Transcriptional induction of GRP78/bip by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis. Mol Cancer Ther. 2009;8:1086–1094.PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Zhang LC, Wang JR, Zhao L, et al. GRP78 upregulation-induced increase in cisplatin sensitivity of spca1 lung cancer cells. Chin Med J (Engl). 2011;124:3341–3346. Zhang LC, Wang JR, Zhao L, et al. GRP78 upregulation-induced increase in cisplatin sensitivity of spca1 lung cancer cells. Chin Med J (Engl). 2011;124:3341–3346.
22.
Zurück zum Zitat Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895–904.CrossRefPubMed Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895–904.CrossRefPubMed
23.
Zurück zum Zitat Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPS) in colorectal cancer. Cancer Metastasis Rev. 2004;23:101–117.CrossRefPubMed Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPS) in colorectal cancer. Cancer Metastasis Rev. 2004;23:101–117.CrossRefPubMed
24.
Zurück zum Zitat Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, her2, and prognosis. Clin Cancer Res. 2004;10:7621–7628.CrossRefPubMed Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, her2, and prognosis. Clin Cancer Res. 2004;10:7621–7628.CrossRefPubMed
25.
Zurück zum Zitat Li Y, Ma J, Guo Q, et al. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Dis Esophagus. 2009;22:664–667.CrossRefPubMed Li Y, Ma J, Guo Q, et al. Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Dis Esophagus. 2009;22:664–667.CrossRefPubMed
Metadaten
Titel
High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma
verfasst von
Guohong Zhao
Jianqin Kang
Kai Jiao
Guanghui Xu
Lei Yang
Shanhong Tang
Hui Zhang
Ying Wang
Yongzhan Nie
Kaichun Wu
Daiming Fan
Hongbo Zhang
Dexin Zhang
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2015
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3689-6

Weitere Artikel der Ausgabe 9/2015

Digestive Diseases and Sciences 9/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.